← All organizations

ImmunoFrontier, Inc.

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

May 1, 2011

Timeline

2000s

Jun 1, 2004
ImmunoFrontier, Inc.— Founded

Drugs by trial phase (1 distinct, 2 trials)

Phase 1 (1 own, 0 via acquisition)

imf-001

Indications

Studied for

Recent trials (4)

NCT01234012Study directorPhase 1May 1, 2011
NCT01234012Lead sponsorPhase 1May 1, 2011
NCT01003808Study directorPhase 1Nov 1, 2009
NCT01003808Lead sponsorPhase 1Nov 1, 2009

Details

Founded: Tokyo, JP Jun 1, 2004
Last known activity: May 1, 2011